CVS looks to 2023 after opioids settlement, Medicare rating decline
Go back to CVS looks to 2023 after opioids settlement, Medicare rating decline| CVS Caremark Corp. (NYSE: CVS) | Delayed: 101.95 +1.47 (1.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.48 | 52 Week High | $106.67 | |||
| Open | $100.89 | 52 Week Low | $69.30 | |||
| Day High | $102.77 | P/E | 27.19 | |||
| Day Low | $100.01 | EPS | $3.75 | |||
| Volume | 8,414,618 | |||||

